Savara Inc.
Organization details
- Legal name
- Savara Inc.
- Former names
- Mast Therapeutics, Inc. Adventrx Pharmaceuticals Inc Biokeys Pharmaceuticals Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Austin
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SVRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001160308
- EIN
- 84-1318182
Board of directors
-
David A. Ramsay · DirectorSince 2023
-
Es-Johansson An Van · DirectorSince 2023
-
Joseph S. McCracken · DirectorSince 2023
-
Matthew Pauls · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Nevan C. Elam · DirectorSince 2023
-
Richard J. Hawkins · DirectorSince 2023
-
Ricky Sun · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.4%
-
98.2%
-
98.2%
-
98.3%
-
98.5%
Board connections
4 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
Cerenome Inc. Same sectorvia Es-Johansson An Van and Richard J. Hawkins
-
Palvella Therapeutics Inc. Same sectorvia Matthew Pauls
-
Pelthos Therapeutics Inc. Same sectorvia Matthew Pauls
-
Rezolute Inc. Same sectorvia Nevan C. Elam
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,362,119
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | Parker Braden C. Officer (Chief Commercial Officer) | Shares withheld for tax | −29,323 | $5.07 | $148,668 |
| Jul 15, 2026 | Lutz Robert Matthew Officer (Chief Fin. & Operating Officer) | Grant or award | +35,000 | — | — |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Option exercise | +75,000 | $1.59 | $119,250 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Shares withheld for tax | −21,682 | $5.50 | $119,251 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Option exercise | +129,350 | $1.23 | $159,101 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Shares withheld for tax | −28,928 | $5.50 | $159,104 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Option exercise | +56,937 | $1.11 | $63,200 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Shares withheld for tax | −11,491 | $5.50 | $63,201 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Option exercise | +218,750 | $1.51 | $330,313 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Shares withheld for tax | −60,057 | $5.50 | $330,314 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Option exercise | +12,500 | $4.45 | $55,625 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Shares withheld for tax | −10,114 | $5.50 | $55,627 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Option exercise | +87,650 | $3.35 | $293,628 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Shares withheld for tax | −53,387 | $5.50 | $293,629 |
| Jun 22, 2026 | Lowrance David L Officer (Chief Financial Officer) | Open-market sale | −394,528 | $5.68 | $2,240,919 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Savara Inc.
Who is the CEO of Savara Inc.?
Matthew Pauls is Savara Inc.'s CHIEF EXECUTIVE OFFICER.
How many directors are on Savara Inc.'s board?
Savara Inc.'s board has 7 directors: David A. Ramsay, Es-Johansson An Van, Joseph S. McCracken, Matthew Pauls, Nevan C. Elam, Richard J. Hawkins and Ricky Sun.
Are Savara Inc. insiders buying or selling shares?
Over the last 12 months, Savara Inc. insiders made no open-market purchases and sold $2.4 million of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="savara-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.